<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Vitamin intake and disease prevention
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Vitamin intake and disease prevention
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Vitamin intake and disease prevention
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kathleen M Fairfield, MD, DrPH
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Christine C Tangney, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Robert S Rosenson, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            David Seres, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Bernard J Gersh, MB, ChB, DPhil, FRCP, MACC
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sara Swenson, MD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 08, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vitamins are chemically unrelated families of organic compounds that are essential in small amounts for normal metabolism. Because most vitamins cannot be synthesized by humans, they need to be ingested in the diet to maintain health and prevent disease. The exceptions to this are pre-vitamin D
         <sub>
          3
         </sub>
         , which is synthesized in the skin following ultraviolet (UV) exposure, and vitamins K2 and B12, which can be synthesized by colonic microbes. These should be distinguished from minerals (such as calcium and iron), some of which are also essential micronutrients.
        </p>
        <p>
         Pregnancy, lactation, alcohol consumption, and chronic use of certain medications increase certain vitamin requirements. The value of vitamin supplementation in the prevention or reversal of many chronic diseases has been disproven in most cases and has proven harmful in others. Randomized trials often fail to confirm the associations seen in observational studies. Additionally, methodological flaws, including lack of standardization of baseline vitamin status and varying doses, often pharmacologic, may contribute to inconsistent findings [
         <a href="#rid1">
          1,2
         </a>
         ].
        </p>
        <p>
         The evidence for enhancing vitamin intake through diet or supplementation to prevent chronic disease is reviewed here. Overviews of individual vitamins, dietary minerals, and dietary supplements are also discussed separately:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5367.html" rel="external">
          "Overview of water-soluble vitamins"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2033.html" rel="external">
          "Overview of vitamin D"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2585.html" rel="external">
          "Overview of dietary trace elements"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          VITAMIN DEFICIENCY AND DEFINITIONS OF ADEQUATE INTAKE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The concept of vitamin deficiency has evolved, from the recognition of obvious vitamin deficiency syndromes such as scurvy, pellagra, beriberi, to the subtle effects of suboptimal vitamin intake on chronic diseases. (See
         <a class="medical medical_review" href="/z/d/html/5360.html" rel="external">
          "Micronutrient deficiencies associated with protein-energy malnutrition in children"
         </a>
         .)
        </p>
        <p>
         Gross vitamin deficiency may be recognized by obvious clinical syndromes, which are still seen in areas of the world with very poor diets  (
         <a class="graphic graphic_table graphicRef79983" href="/z/d/graphic/79983.html" rel="external">
          table 1
         </a>
         ). In resource-rich societies, they also occur in several particular populations, including some older adults; vegans; new immigrants who may arrive with preexisting deficiencies [
         <a href="#rid3">
          3,4
         </a>
         ]; those experiencing significant poverty; patients with alcohol use disorder, malabsorption disorders, limited sun exposure, history of bariatric surgery, or inborn errors of metabolism; and those undergoing hemodialysis or receiving
         <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">
          parenteral nutrition
         </a>
         (
         <a class="graphic graphic_table graphicRef81037" href="/z/d/graphic/81037.html" rel="external">
          table 2
         </a>
         ). However, the levels of numerous vitamins are impacted by underlying disease, and low levels may not reflect actual deficiency.
        </p>
        <p>
         There are several ways of defining optimal vitamin intake. Dietary reference intakes (DRIs) represent four concepts:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Recommended Dietary Allowance (RDA)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Adequate Intake (AI)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Estimated Average Requirement (EAR)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tolerable Upper Intake Level (UL)
        </p>
        <p>
        </p>
        <p>
         In the United States, DRIs are established by the National Academy of Sciences, National Research Council, and the Institute of Medicine (IOM)  (
         <a class="graphic graphic_table graphicRef106207" href="/z/d/graphic/106207.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef51953" href="/z/d/graphic/51953.html" rel="external">
          table 4
         </a>
         and
         <a class="graphic graphic_table graphicRef81151" href="/z/d/graphic/81151.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_table graphicRef69963" href="/z/d/graphic/69963.html" rel="external">
          table 6
         </a>
         ). For clinical purposes, we use the RDA, which is the recommended daily intake that is sufficient to meet the dietary requirement of nearly all healthy people. The AI is used when the RDA cannot be determined (including vitamin supplementation in infants &lt;12 months and for vitamin K)  (
         <a class="graphic graphic_table graphicRef106207" href="/z/d/graphic/106207.html" rel="external">
          table 3
         </a>
         ). However, AI levels may not be adequate for all people, since they are largely based upon observational studies of intake among healthy individuals.
        </p>
        <p class="headingAnchor" id="H74132943">
         <span class="h2">
          Testing
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although measurement of serum levels of several vitamins is widely available, testing for deficiencies is usually unwarranted:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For some vitamins, there is insufficient information about the optimum serum levels of vitamins, making it difficult to interpret the results and diagnose subtle deficiency states.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         There is insufficient evidence that vitamin supplementation can prevent disease in most healthy adults with low serum levels of vitamins (apart from those individuals with specific diets or medical conditions).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The levels of numerous vitamins are impacted by underlying disease, and low levels may not reflect actual deficiency.
        </p>
        <p>
        </p>
        <p>
         However, testing remains appropriate in certain clinical situations where deficiencies are suspected or are part of the clinical evaluation (eg, measuring 25-hydroxyvitamin D in patients with osteoporosis and
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         in patients with cognitive decline of unknown etiology). (See
         <a class="medical medical_review" href="/z/d/html/5083.html" rel="external">
          "Evaluation of cognitive impairment and dementia", section on 'Laboratory testing'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2060.html" rel="external">
          "Evaluation and treatment of premenopausal osteoporosis", section on 'Initial evaluation'
         </a>
         .)
        </p>
        <p>
         Additional information about genetic polymorphisms, which increase requirements for specific vitamins, is likely to become available. This appears to be the case for certain genes, such as those controlling the metabolism of folate and vitamin D. However, there is insufficient understanding of individual risk to warrant routine testing for polymorphisms. (See
         <a class="medical medical_review" href="/z/d/html/2044.html" rel="external">
          "Pathogenesis of osteoporosis", section on 'Genetics'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          FOLIC ACID
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Folate is the natural form of the vitamin found in food and is present in green, leafy vegetables, fruits, cereals, grains, nuts, and meats.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          Folic acid
         </a>
         is the synthetic form of the vitamin that is included in supplements and food fortification and has many of the same biologic effects as folate, but it is more bioavailable and therefore more effective dose for dose [
         <a href="#rid5">
          5
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Some evidence suggests that the metabolism of
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         differs from folate and may have toxicities under certain circumstances [
         <a href="#rid6">
          6
         </a>
         ]. Gross deficiency of folate leads to megaloblastic anemia. (See
         <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">
          "Clinical manifestations and diagnosis of vitamin B12 and folate deficiency", section on 'Diagnostic evaluation'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          Folic acid
         </a>
         has been studied for prevention of many disease states. However, the only well-established benefit of folic acid supplementation is the prevention of neural tube defects. In the United States, concern over the risk for neural tube defects led to nationwide folate fortification of all enriched cereal grains beginning in 1998.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Neural tube defects
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          Folic acid
         </a>
         supplementation reduces the risk of neural tube defects, probably because folate is required for normal cell division. This has been shown in multiple observational studies and confirmed by randomized trials [
         <a href="#rid7">
          7-11
         </a>
         ]. Females of childbearing potential are recommended to consume 400 mcg of folic acid daily, with higher intake recommended for those with certain risk factors  (
         <a class="graphic graphic_table graphicRef111473" href="/z/d/graphic/111473.html" rel="external">
          table 7
         </a>
         ). This is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/423.html" rel="external">
          "Preconception and prenatal folic acid supplementation", section on 'Folic acid supplementation for preventing NTDs'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Folate deficiency may contribute to aberrant deoxyribonucleic acid (DNA) synthesis and carcinogenesis by decreasing methionine availability and interfering with normal DNA methylation. Observational evidence suggests that sufficient folate intake might be associated with prevention of cancers in certain populations at increased risk [
         <a href="#rid12">
          12-15
         </a>
         ], although randomized trials have not confirmed any benefits of
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         supplementation and have also raised the possibility of harm [
         <a href="#rid16">
          16-19
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7153.html" rel="external">
          "Causes and pathophysiology of vitamin B12 and folate deficiencies"
         </a>
         .)
        </p>
        <p>
         In a 2013 meta-analysis of randomized trials (including three trials and over 2600 patients with colorectal adenoma, and 10 trials and 47,000 subjects evaluating
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         for the prevention of cardiovascular disease [CVD]), there was no difference in overall cancer incidence among those assigned to folic acid compared with placebo over 5.2 years of treatment [
         <a href="#rid20">
          20
         </a>
         ]. In addition, there was no difference in the incidence of specific cancers between the groups. Among the included trials, the doses of folic acid ranged from 0.5 to 5 mg daily, which is higher than the RDA for the healthy adult. An additional limitation was the short intervention duration which may be insufficient to identify any long-term benefits or harms. Finally, the included trials did not address underlying nutritional status and other preventive measures.
        </p>
        <p class="headingAnchor" id="H64967839">
         <span class="h2">
          Cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         High levels of homocysteine are associated with an increased risk of CVD [
         <a href="#rid21">
          21
         </a>
         ], and supplementation with
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         ,
         <a class="drug drug_general" data-topicid="9839" href="/z/d/drug information/9839.html" rel="external">
          vitamin B6
         </a>
         , and
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         can lower homocysteine levels. However, there is no evidence of efficacy of folate supplementation in the prevention of CVD. This is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/6837.html" rel="external">
          "Overview of homocysteine", section on 'Disease associations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         Elevated homocysteine levels have been associated with osteoporosis and dementia. It is not known whether these associations are causal or represent overall dietary quality, and there is limited high-quality evidence that lowering homocysteine levels with
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         supplementation is effective in preventing these conditions. (See
         <a class="medical medical_review" href="/z/d/html/6837.html" rel="external">
          "Overview of homocysteine", section on 'Disease associations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5079.html" rel="external">
          "Risk factors for cognitive decline and dementia", section on 'Homocysteine'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5075.html" rel="external">
          "Prevention of dementia", section on 'Vitamins B6, B12, and folate'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2064.html" rel="external">
          "Overview of the management of low bone mass and osteoporosis in postmenopausal women"
         </a>
         .)
        </p>
        <p>
         In addition, excess folate intake (approximately twice the recommended dose) has been associated with peripheral neuropathy, despite normal serum levels of
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         , in older individuals who have a common polymorphism in the transcobalamin vitamin B12 transporter gene [
         <a href="#rid22">
          22
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h1">
          VITAMIN D
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is controversy over whether subclinical vitamin D deficiency or insufficiency contribute to the development of osteoporosis, falls, and fractures in older adults. The concept of vitamin D “insufficiency” resulted from associations made in observational studies, but randomized trials have not demonstrated benefit of supplementation in patients with poor vitamin D status (defined as &lt;10 or &lt;20 ng/mL [&lt;25 or &lt;50 nmol/L]).
        </p>
        <p>
         Serum 25-hydroxyvitamin D should be measured in patients who are at risk for inadequate serum vitamin D concentrations, including institutionalized individuals, patients being evaluated for osteoporosis, and patients with malabsorption (eg, Crohn disease and celiac disease). The evaluation and supplementation of vitamin D in patients with vitamin D deficient states and in patients with osteoporosis are discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2022.html" rel="external">
          "Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2023.html" rel="external">
          "Calcium and vitamin D supplementation in osteoporosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/14590.html" rel="external">
          "Vitamin D insufficiency and deficiency in children and adolescents"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13915.html" rel="external">
          "Vitamin D and extraskeletal health"
         </a>
         .)
        </p>
        <p>
         The intake at which the dose of vitamin D becomes toxic is not clear. The Institute of Medicine (IOM) has defined the upper limit for vitamin D as 4000 units daily for healthy adults [
         <a href="#rid23">
          23
         </a>
         ]. This is also the upper limit for pregnant and lactating individuals. It is important to ask patients about additional dietary supplements (some of which contain vitamin D) before prescribing supplemental vitamin D [
         <a href="#rid24">
          24
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2022.html" rel="external">
          "Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment", section on 'Vitamin D replacement'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h2">
          Osteoporosis
         </span>
         <span class="headingEndMark">
          —
         </span>
         Physiologic doses of vitamin D attenuate bone loss and may decrease fracture rate. Evidence regarding the efficacy and necessary dose of vitamin D to prevent osteoporosis and reduce fracture risk, as well as the possible need for concurrent calcium therapy, is discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/2022.html" rel="external">
          "Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment", section on 'Clinical manifestations'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2023.html" rel="external">
          "Calcium and vitamin D supplementation in osteoporosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h2">
          Falls
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are several meta-analyses of randomized trials showing a reduction in risk of falls following vitamin D supplementation, particularly when the baseline vitamin D status is poor [
         <a href="#rid25">
          25-29
         </a>
         ]. This is reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3014.html" rel="external">
          "Falls: Prevention in community-dwelling older persons", section on 'Vitamin D supplementation'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/13915.html" rel="external">
          "Vitamin D and extraskeletal health", section on 'Falls'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H64967914">
         <span class="h2">
          Cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         While there are biologic reasons why vitamin D might protect against cancer, evidence for this effect in humans is mixed, and expert groups do not recommend vitamin D supplements for the specific purpose of cancer prevention [
         <a href="#rid30">
          30
         </a>
         ]. This is reviewed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/13915.html" rel="external">
          "Vitamin D and extraskeletal health", section on 'Cancer'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H217626177">
         <span class="h2">
          Mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Studies evaluating the relationship between vitamin D levels and mortality have demonstrated conflicting results. The evidence regarding vitamin D and mortality is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13915.html" rel="external">
          "Vitamin D and extraskeletal health", section on 'Mortality'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2411268321">
         <span class="h2">
          Other
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to its role in calcium and bone homeostasis, vitamin D potentially regulates many cellular and immune functions. Vitamin D deficiency has been implicated as a risk factor for many diseases, although a causal relationship between poor vitamin D status and major diseases, including infections, autoimmune disorders, cardiovascular, and metabolic diseases, has not been established [
         <a href="#rid31">
          31
         </a>
         ]. For example, despite observational studies identifying an association between low vitamin D levels and unfavorable coronavirus disease 2019 (COVID-19) outcomes, randomized trials have failed to demonstrate the efficacy of vitamin D supplementation in treating COVID-19 [
         <a href="#rid32">
          32
         </a>
         ]. The role of vitamin D in extraskeletal health is reviewed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/13915.html" rel="external">
          "Vitamin D and extraskeletal health"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          ANTIOXIDANTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nutritional antioxidants include those consumed from both dietary and supplemental sources. The common dietary antioxidants are vitamins A (including some carotenoids with little
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         activity), C, and E. The bioavailability of nutritional antioxidants may be impacted by the simultaneous consumption of other foods and drinks. Dietary antioxidants most often refer to those found in fruits, vegetables, and other foods, such as nuts, oils, seeds, and wine.
        </p>
        <p class="headingAnchor" id="H3684990307">
         <span class="h2">
          Potential mechanisms of benefit
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is hypothesized that antioxidants can prevent cancer and cardiovascular disease (CVD) by augmenting the body's ability to dispose of toxic free radicals, thereby retarding oxidative damage [
         <a href="#rid33">
          33
         </a>
         ]. Inflammation and oxidative stress are critical to the initiation and progression of atherosclerosis; oxidation of proteins and lipid peroxidation of membrane polyunsaturated fatty acids in lipoproteins can facilitate the development of atherosclerotic lesions  (
         <a class="graphic graphic_figure graphicRef72955" href="/z/d/graphic/72955.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
         Ingestion of nutritional antioxidants may retard atherosclerosis through several different mechanisms  (
         <a class="graphic graphic_figure graphicRef64231" href="/z/d/graphic/64231.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid34">
          34-36
         </a>
         ]. Antioxidants provide cellular protection by inducing enzyme-catalyzed processes that alter the steady state levels of crucial regulatory elements through signal transduction pathways, especially the nuclear factor erythroid 2 (Nrf2) transcription factor and electrophile response element (EpRE) to which Nrf2 binds. Our understanding of how these dietary antioxidants and possibly supplemental antioxidants effect protection against oxidative damage continues to evolve [
         <a href="#rid37">
          37
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H2413964078">
         <span class="h3">
          Dietary sources
         </span>
         <span class="headingEndMark">
          —
         </span>
         In observational studies, diets high in vegetables and fruits that are rich in antioxidants are associated with a reduced risk of cancer and CVD [
         <a href="#rid38">
          38,39
         </a>
         ]. However, the association may be due to non-vitamin antioxidants, other compounds such as flavonoids, the substitution of dietary meat and fat with vegetables and fruits, or the other components of healthy lifestyles seen in people who consume this dietary pattern.
        </p>
        <p>
         The empirical dietary inflammatory pattern (EDIP), a food-based dietary index, has been developed to evaluate the inflammatory potential of diets, considering consumption of foods rich in antioxidants as well as foods with high proinflammatory potential; a higher score reflects a proinflammatory dietary pattern [
         <a href="#rid40">
          40
         </a>
         ]. In an observational analysis, a higher EDIP was associated with elevated circulating inflammatory markers including lower adiponectin, tumor necrosis factor (TNF) alpha-R2, and high-sensitivity C-reactive protein (hs-CRP) [
         <a href="#rid41">
          41
         </a>
         ]. In a large observational study including over five million person-years of follow-up, a higher EDIP was associated with increased risk of incident CVD, coronary heart disease, and stroke (hazard ratio [HR] 1.38, 95% CI 1.31-1.46; HR 1.46, 95% CI 1.36-1.56; HR 1.28, 95% CI 1.17-1.39) [
         <a href="#rid42">
          42
         </a>
         ]. These benefits were not identified in randomized trials.
        </p>
        <p class="headingAnchor" id="H931630773">
         <span class="h3">
          No role for supplements
         </span>
         <span class="headingEndMark">
          —
         </span>
         We do not advise the use of antioxidant supplements strictly to prevent the development of atherosclerotic CVD or cancer. This is consistent with the recommendations from the US Preventive Services Task Force (USPSTF), which found insufficient evidence to recommend for or against supplements of
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         ,
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         , or antioxidant combination supplements for the prevention of atherosclerotic CVD and recommends
         <strong>
          against
         </strong>
         the use of
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         or
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplements for this purpose [
         <a href="#rid30">
          30
         </a>
         ]
        </p>
        <p>
         Randomized trials evaluating antioxidant supplements have not found a reduction in the risk of cancer [
         <a href="#rid43">
          43
         </a>
         ]. Further, supplementation with
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         ,
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         , and
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         (provitamin A carotenoid) has not been shown to be useful for primary or secondary prevention of CVD whether given alone or in combination [
         <a href="#rid44">
          44-48
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Vitamin A and the carotenoids
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          Vitamin A
         </a>
         consists of preformed vitamin A (retinol) and the provitamin A carotenoids (alpha- and beta-carotenes) that can be converted into vitamin A. Retinol is only found in animal products (eg, liver, milk, egg yolk, butter) and supplements. The provitamin A carotenoids are ubiquitous in yellow and orange fruits and vegetables as well as leafy green vegetables. In addition to antioxidant properties, retinol can induce cellular differentiation. (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A", section on 'Cellular differentiation'
         </a>
         .)
        </p>
        <p>
         Most diets in resource-rich countries contain adequate amounts of retinol and carotenoids. Vegetarians, including vegans, do not need to take
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         supplements if they eat an adequate variety of carotenoid containing vegetables. While vitamin A supplementation for children ages 6 through 59 months in resource-limited countries is recommended to prevent blindness and reduce mortality, dietary intake of vitamin A in other countries is generally adequate [
         <a href="#rid49">
          49,50
         </a>
         ]. Thus, in countries with adequate resources, routine vitamin A or
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         supplementation is not warranted given lack of proven efficacy and the possibility of harm. A detailed discussion of indications for vitamin A supplementation can be found elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A", section on 'Requirements'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h3">
          Cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Trials evaluating
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         or carotenoid supplementation have reported no benefit or an increased risk of cancer [
         <a href="#rid51">
          51-61
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Two large, randomized trials assessed the effect of
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         supplementation on the risk of lung cancer among males at increased risk because of smoking or asbestos exposure [
         <a href="#rid51">
          51,52
         </a>
         ]. In both trials, there was an increased lung cancer risk among men who received the supplements; the excess risk resolved over time once supplements were stopped [
         <a href="#rid53">
          53
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4604.html" rel="external">
          "Chemoprevention of lung cancer", section on 'Investigative strategies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the ATBC Cancer Prevention Study, there was an increase in both prostate cancer incidence and mortality among participants randomly assigned to receive
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         [
         <a href="#rid62">
          62
         </a>
         ]. The excess risk resolved over time (four to six years) after supplements were stopped [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In pooled analysis from a USPSTF systematic review of 84 studies, beta carotene (with or without
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         ) was associated with an increased risk of lung cancer (odds ratio [OR] 1.20, 95% CI 1.01-1.42) among persons at high risk of lung cancer [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         The increase in risk of cancer in randomized trials of
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         as described above (albeit in high-risk individuals) has dampened enthusiasm for further clinical trials of antioxidants in cancer prevention.
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h3">
          Cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Randomized trials of
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         and
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         have shown no benefit for the primary or secondary prevention of coronary heart disease (CHD), and further, one trial, as well as a USPSTF systematic review, suggested potential harm with regard to cardiovascular mortality [
         <a href="#rid47">
          47,63
         </a>
         ]. This is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1505.html" rel="external">
          "Prevention of cardiovascular disease events in those with established disease (secondary prevention) or at very high risk", section on 'Therapies with uncertain or no benefit'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E", section on 'Potential risks'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Immunity
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          Vitamin A
         </a>
         improves immunity in children living in resource-limited countries where dietary intake is inadequate and life-threatening infectious diseases are common. In a meta-analysis including 12 randomized trials, vitamin A supplementation in children with measles in resource-limited settings reduced mortality in both hospitalized and non-hospitalized patients [
         <a href="#rid64">
          64
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3021.html" rel="external">
          "Measles: Clinical manifestations, diagnosis, treatment, and prevention", section on 'Vitamin A'
         </a>
         .)
        </p>
        <p>
         The World Health Organization (WHO) recommends community-based
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         supplementation for children in resource-limited countries even in the absence of signs and symptoms of deficiency [
         <a href="#rid65">
          65
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A", section on 'Special populations'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H23">
         <span class="h3">
          Fractures
         </span>
         <span class="headingEndMark">
          —
         </span>
         Consistent evidence from observational studies suggests that higher
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         intake (specifically retinol) is a risk factor for osteopenia and fractures [
         <a href="#rid66">
          66-68
         </a>
         ]. As an example, over 72,000 postmenopausal females ages 34 to 77 years were followed for 18 years in the Nurses’ Health Study [
         <a href="#rid67">
          67
         </a>
         ]. Those in the highest quintile of total vitamin A intake had an increased risk for hip fracture compared with those in the lowest quintile (relative risk [RR] 1.48, 95% CI 1.05-2.07). Thus, patients should be cautioned against diets high in retinol, especially if they have other risk factors for osteopenia, and should avoid vitamin A supplements if their dietary intake is high. (See
         <a class="medical medical_review" href="/z/d/html/2036.html" rel="external">
          "Drugs that affect bone metabolism", section on 'Vitamin A and synthetic retinoids'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H119442565">
         <span class="h3">
          Congenital anomalies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Supplements with preformed
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         in doses &gt;10,000 international units taken in the first trimester of pregnancy have been shown to increase the risk of congenital anomalies [
         <a href="#rid69">
          69
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A", section on 'Teratogenic effects'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h3">
          Cataracts and macular degeneration
         </span>
         <span class="headingEndMark">
          —
         </span>
         In randomized trials, there was no benefit of
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         or carotenoid supplementation in the primary prevention of cataracts or macular degeneration. (See
         <a class="medical medical_review" href="/z/d/html/6904.html" rel="external">
          "Cataract in adults", section on 'Prevention'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6901.html" rel="external">
          "Age-related macular degeneration", section on 'Limited role for antioxidant vitamins'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9268837">
         <span class="h2">
          Vitamin C
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          Vitamin C
         </a>
         (ascorbic acid) is a water-soluble vitamin and is found in particularly high amounts in citrus fruits, peppers, tomatoes, and leafy greens. Evidence does not support the use of vitamin C supplementation for chronic disease prevention, including cancer or primary or secondary prevention of CHD.
        </p>
        <p class="headingAnchor" id="H9268896">
         <span class="h3">
          Cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Large randomized trials have found no reduction in the incidence of cancers among patients given
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         supplementation [
         <a href="#rid70">
          70
         </a>
         ]. As examples:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the Physicians' Health Study II, over 14,000 males age ≥50 were randomly assigned to receive
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         500 mg daily or placebo [
         <a href="#rid71">
          71
         </a>
         ]. After eight years of treatment, there was no difference in the incidence of cancers between groups, and during an additional three years of post-trial follow-up, there was no difference in the risk of all cancers and prostate cancers between the two groups [
         <a href="#rid72">
          72
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In an analysis of the Women's Antioxidant Cardiovascular Study including almost 8000 females,
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         500 mg daily for 9.4 years had no effect on the incidence of cancers [
         <a href="#rid56">
          56
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9268903">
         <span class="h3">
          Cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Randomized trials have shown no benefit of
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         for primary or secondary prevention of CHD. (See
         <a class="medical medical_review" href="/z/d/html/16307.html" rel="external">
          "Overview of possible risk factors for cardiovascular disease", section on 'Vitamins, antioxidants and homocysteine'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1408343401">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          Vitamin C
         </a>
         may have a minor role in reducing the duration of cold symptoms in adults, although the clinical importance of this is likely small [
         <a href="#rid73">
          73
         </a>
         ]. Further, there is no evidence that regular vitamin C supplementation reduces the incidence of the common cold. (See
         <a class="medical medical_review" href="/z/d/html/6868.html" rel="external">
          "The common cold in adults: Treatment and prevention"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H119442659">
         <span class="h3">
          Kidney stones
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          Vitamin C
         </a>
         increases urinary oxalate excretion and may increase the risk of kidney stones. This is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7375.html" rel="external">
          "Kidney stones in adults: Epidemiology and risk factors"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9268910">
         <span class="h3">
          Cataracts and macular degeneration
         </span>
         <span class="headingEndMark">
          —
         </span>
         In randomized trials, there was no benefit of
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         supplementation in the primary prevention of cataracts or macular degeneration [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6904.html" rel="external">
          "Cataract in adults", section on 'Prevention'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6901.html" rel="external">
          "Age-related macular degeneration", section on 'Limited role for antioxidant vitamins'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H26">
         <span class="h2">
          Vitamin E
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a number of biologically active
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         compounds, including alpha-, beta-, gamma-, and delta- tocopherol. Vitamin E is present in vegetable oils such as wheat germ, sunflower, safflower, and lesser amounts in corn and soybean oils. Nuts, especially almonds, hazelnuts, peanuts, and seeds (eg, sunflower) are good sources of vitamin E. Additionally, vitamin E is found in green leafy vegetables such as broccoli and spinach. (See
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E", section on 'Sources'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E", section on 'Chemistry and nomenclature'
         </a>
         .)
        </p>
        <p>
         Evidence does not support a role for
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation in the prevention or treatment of cancers, CVD, dementia, and infection. Additionally, the best available evidence suggests that high-dose vitamin E (≥400 units daily) might increase all-cause mortality [
         <a href="#rid75">
          75
         </a>
         ]. In particular, individuals taking anticoagulants should be advised against high doses of vitamin E because of the synergistic action of vitamin E with these drugs. Vitamin E is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1666395133">
         <span class="h3">
          Cancer
         </span>
         <span class="headingEndMark">
          —
         </span>
         Observational studies have found variable effects of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         on certain cancers, particularly within subgroups such as people who smoke [
         <a href="#rid57">
          57-59,76-78
         </a>
         ], but most randomized trials do not support a protective effect [
         <a href="#rid56">
          56,61,71,79-81
         </a>
         ].
        </p>
        <p>
         As an example, in the Women's Health Study, a randomized trial that followed almost 40,000 healthy females age ≥45 for a mean of 10.1 years, supplementation with 600 units of natural-source
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         on alternate days had no effect on the incidence of all cancers, breast cancer, lung cancer, colon cancer, or cancer mortality compared with placebo [
         <a href="#rid79">
          79
         </a>
         ].
        </p>
        <p>
         In addition, randomized trials of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         for prevention of prostate cancer have found conflicting results (see
         <a class="medical medical_review" href="/z/d/html/6949.html" rel="external">
          "Chemoprevention strategies in prostate cancer", section on 'Vitamin E'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the ATBC Cancer Prevention Study, there was a 16 percent decrease in prostate cancer mortality over 18 years of follow-up (RR 0.84, 95% CI 0.70-0.99) among male smokers randomly assigned to receive 50 mg (75 units) of alpha-tocopherol for five to eight years, compared with placebo [
         <a href="#rid82">
          82
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The SELECT trial followed over 35,000 males (ages ≥50 for African American participants and ages ≥55 for other participants) for a median of seven years [
         <a href="#rid83">
          83
         </a>
         ]. Compared with placebo,
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation (400 units daily) was associated with an increased risk of prostate cancer (HR 1.17, 99% CI 1.004-1.36).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H28">
         <span class="h3">
          Cardiovascular disease
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nearly all randomized trials of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         have shown no benefit for the primary or secondary prevention of CHD [
         <a href="#rid63">
          63
         </a>
         ]. Additionally, vitamin E supplementation may increase the risk of heart failure [
         <a href="#rid80">
          80
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/16307.html" rel="external">
          "Overview of possible risk factors for cardiovascular disease", section on 'Vitamins, antioxidants and homocysteine'
         </a>
         .)
        </p>
        <p>
         Additionally, randomized trials have not found overall benefit of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation in stroke prevention. In a meta-analysis including nine randomized trials, vitamin E supplementation had no effect on risk of total stroke [
         <a href="#rid84">
          84
         </a>
         ]. Findings were similar for patients with and without established CVD. Vitamin E supplementation was, however, associated with an increased risk of hemorrhagic stroke although a decreased risk of ischemic stroke (RR 1.22, 95% CI 1.00-1.48; RR 0.90, 95% CI 0.82-0.99, respectively).
        </p>
        <p class="headingAnchor" id="H30">
         <span class="h3">
          Dementia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although observational studies suggested that increased dietary intake of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         or vitamin E supplementation might protect against the development of Alzheimer disease and vascular dementia [
         <a href="#rid85">
          85-87
         </a>
         ], randomized trials have found no benefit of vitamin E supplementation for the prevention of dementia [
         <a href="#rid88">
          88,89
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5075.html" rel="external">
          "Prevention of dementia", section on 'Antioxidant vitamins'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5073.html" rel="external">
          "Treatment of Alzheimer disease", section on 'Antioxidants'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H31">
         <span class="h3">
          Infection
         </span>
         <span class="headingEndMark">
          —
         </span>
         Several studies have reported that supplementation with
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         improves the immune response [
         <a href="#rid90">
          90,91
         </a>
         ]. Such an effect is of particular interest in older adults, in whom an age-related decline in immune response may increase the risk of infections and related complications. However, randomized trials examining vitamin E to prevent infections in older adults have not found clinical benefits [
         <a href="#rid92">
          92-94
         </a>
         ]. Large trials found no reduction in the incidence of respiratory infections among institutionalized [
         <a href="#rid92">
          92,93
         </a>
         ] and noninstitutionalized [
         <a href="#rid94">
          94
         </a>
         ] older adult patients receiving daily vitamin E supplements. Furthermore, in a trial of noninstitutionalized older adults experiencing a respiratory infection, those who received vitamin E (200 mg daily) experienced more symptoms, a longer total illness duration (19 versus 14 days), and a higher frequency of fever and activity restriction [
         <a href="#rid94">
          94
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H32">
         <span class="h3">
          Venous thromboembolism
         </span>
         <span class="headingEndMark">
          —
         </span>
         High doses of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         may interfere with vitamin K and affect coagulation. As an example, in a secondary analysis from the Women's Health Study, females randomly assigned to receive 600 units vitamin E every other day had a lower risk of venous thromboembolism than those receiving placebo (HR 0.79, 95% CI 0.66-0.94) [
         <a href="#rid95">
          95
         </a>
         ]. This effect needs to be confirmed in other randomized trials before vitamin E can be recommended for prevention of venous thromboembolism.
        </p>
        <p class="headingAnchor" id="H418486">
         <span class="h3">
          Cataracts and macular degeneration
         </span>
         <span class="headingEndMark">
          —
         </span>
         Randomized trials have found no benefit of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation in the prevention of cataracts or macular degeneration [
         <a href="#rid74">
          74,96
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6904.html" rel="external">
          "Cataract in adults", section on 'Prevention'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6901.html" rel="external">
          "Age-related macular degeneration", section on 'Limited role for antioxidant vitamins'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H33">
         <span class="h3">
          All-cause mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         There is no evidence of a mortality effect of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A meta-analysis of randomized trials of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation examined the effects of supplementation on all-cause mortality [
         <a href="#rid75">
          75
         </a>
         ]. Although there was no overall effect on mortality across all trials, mortality was increased among patients who received high-dose vitamin E supplementation (≥400 units daily), with an increase in mortality of 39 per 10,000 persons, 95% CI 3-74 per 10,000 persons. There also appeared to be a dose-response relationship, with patients treated with low-dose supplementation experiencing a decrease in mortality. However, trials evaluating these doses were often performed in malnourished populations or used with supplements in combination with vitamin E. Further, several trials of high-dose supplementation were performed in patients with chronic diseases, and it is unclear whether the observed harm from such supplementation would carry over to a healthier population.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Similar to the overall results of the above analysis, another meta-analysis that did not stratify trials by dose found no overall effect of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation on all-cause mortality [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H9052545">
         <span class="h1">
          VITAMIN B2 (RIBOFLAVIN)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Vitamin B2 is found in many commonly consumed foods, including milk, meat, eggs, cereal, and green leafy vegetables. This may explain why overt riboflavin deficiency is rare.
        </p>
        <p>
         There is no strong evidence that supplemental vitamin B2 is helpful in healthy people eating a balanced diet, although B2 supplementation may have a role in management in adults with episodic migraines. This is discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/3345.html" rel="external">
          "Preventive treatment of episodic migraine in adults", section on 'Other agents'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H41">
         <span class="h1">
          VITAMIN B6 (PYRIDOXINE)
         </span>
         <span class="headingEndMark">
          —
         </span>
         <a class="drug drug_general" data-topicid="9839" href="/z/d/drug information/9839.html" rel="external">
          Vitamin B6
         </a>
         is found in bananas, nuts, and many common vegetables such as potatoes, green beans, cauliflower, and carrots. Vitamin B6 is thought to reduce the risk of cardiovascular disease (CVD) and cancer. However, it has been difficult to distinguish the effects of vitamin B6 from that of other vitamins and of other substances in fruits and vegetables [
         <a href="#rid97">
          97
         </a>
         ].
        </p>
        <p>
         High levels of homocysteine are associated with an increased risk of CVD, and supplementation with
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         ,
         <a class="drug drug_general" data-topicid="9839" href="/z/d/drug information/9839.html" rel="external">
          vitamin B6
         </a>
         , and
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         can lower homocysteine levels. However, randomized trials of supplementation for secondary prevention do not support the hypothesis that these vitamins prevent CVD [
         <a href="#rid98">
          98-102
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6837.html" rel="external">
          "Overview of homocysteine"
         </a>
         .)
        </p>
        <p>
         Higher levels of
         <a class="drug drug_general" data-topicid="9839" href="/z/d/drug information/9839.html" rel="external">
          vitamin B6
         </a>
         and their metabolites are associated with a lower risk of cancer. However, randomized trials of B6 supplementation have not demonstrated a benefit in cancer risk reduction [
         <a href="#rid103">
          103
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H45">
         <span class="h1">
          VITAMIN B12 (COBALAMIN)
         </span>
         <span class="headingEndMark">
          —
         </span>
         Suboptimal
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         levels are most commonly caused by poor absorption or inadequate intake of vitamin B12-containing food sources (eg, liver, milk, fish, meat). Malabsorption of cobalamin is primarily the result of inability to release cobalamin from dietary proteins, especially in the presence of autoimmune antibodies against intrinsic factor or reduced gastric acid secretion. Patients treated with
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         also have decreased vitamin B12 absorption (see
         <a class="medical medical_review" href="/z/d/html/1809.html" rel="external">
          "Metformin in the treatment of adults with type 2 diabetes mellitus", section on 'Vitamin B12 deficiency'
         </a>
         ). In older adults, gastric atrophy and hypochlorhydria result in reduced gastric acid and inefficient vitamin B12 absorption. Low levels of vitamin B12 can also be seen among people following a vegan diet. (See
         <a class="local">
          'Special diets'
         </a>
         below and
         <a class="medical medical_review" href="/z/d/html/7153.html" rel="external">
          "Causes and pathophysiology of vitamin B12 and folate deficiencies", section on 'Causes of vitamin B12 deficiency'
         </a>
         .)
        </p>
        <p>
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          Vitamin B12
         </a>
         deficiency is associated with neuropsychiatric manifestations and megaloblastic anemia. This is discussed in detail elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">
          "Clinical manifestations and diagnosis of vitamin B12 and folate deficiency", section on 'Clinical presentation'
         </a>
         .)
        </p>
        <p>
         Measuring
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         levels may be indicated in individuals at increased risk for poor vitamin B12 intake, including vegans, people taking
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         , those with alcohol use disorder, and people with little dietary variation or poor-quality diets (such as some older adults and people experiencing poverty)  (
         <a class="graphic graphic_algorithm graphicRef113189" href="/z/d/graphic/113189.html" rel="external">
          algorithm 1
         </a>
         ). In the absence of a strong evidence base about the impact of supplementation on clinical outcomes, we recommend using clinical judgment and shared decision-making to determine when to test asymptomatic but at-risk people for vitamin B12 deficiency. Similarly, there is not yet an evidence base to recommend routine supplementation of at-risk people. However, vitamin B12 supplementation is well-tolerated without significant adverse effects, and we suggest it for some at-risk patients, such as those adhering to a vegan diet (see
         <a class="local">
          'Special diets'
         </a>
         below) [
         <a href="#rid104">
          104,105
         </a>
         ].
        </p>
        <p>
         Because impaired
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         absorption is so common among older adults, consumption of foods fortified with vitamin B12 has been advised. Taking a multivitamin is a reasonable alternative [
         <a href="#rid106">
          106,107
         </a>
         ].
        </p>
        <p>
         The evaluation and treatment of B12 deficiency is reviewed in detail elsewhere  (
         <a class="graphic graphic_algorithm graphicRef131424" href="/z/d/graphic/131424.html" rel="external">
          algorithm 2
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/7155.html" rel="external">
          "Clinical manifestations and diagnosis of vitamin B12 and folate deficiency"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/7154.html" rel="external">
          "Treatment of vitamin B12 and folate deficiencies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H48">
         <span class="h1">
          MULTIVITAMINS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most generic and brand-name multivitamins contain 50 to 150 percent of the Recommended Dietary Allowance (RDA) for all vitamins, including
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         and vitamins A, C, D, E, B2, B6, and B12. However, there are several variations of multivitamins, such as B vitamins alone, multivitamins with minerals, and multivitamins for specific groups (eg, females, males, younger and older populations). The proposed rationale for taking a daily multivitamin for adults includes known or potential effectiveness for some of the component vitamins, relative safety in low doses, low cost (one multivitamin per day can cost as little as USD $15 to $35 per year in the United States, but can also be much more expensive), and efficiency of taking one pill rather than multiple vitamin pills.
        </p>
        <p>
         Many multivitamins contain minerals as well, but the doses of minerals in these supplements (such as calcium and iron) are well below one daily value (DV). DVs are reference values that provide recommended dietary nutrient intakes that appear on package labels. Toxicities of individual minerals are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2585.html" rel="external">
          "Overview of dietary trace elements"
         </a>
         .)
        </p>
        <p>
         Multivitamin supplementation should be considered for patients at risk for vitamin deficiency, such as those with alcohol use disorder, poor-quality diets with low fruit and vegetable intake, malabsorption, a vegan diet, a history of bariatric surgery, or some inborn errors of metabolism, as well as those being treated with hemodialysis or
         <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">
          parenteral nutrition
         </a>
         . In addition, in patients with a specific vitamin deficiency, a multivitamin may be a reasonable choice over supplementation with individual vitamins if a multivitamin is less costly and the formulation contains an appropriate dose. (See
         <a class="medical medical_review" href="/z/d/html/323.html" rel="external">
          "Management of moderate and severe alcohol withdrawal syndromes", section on 'Management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/587.html" rel="external">
          "Bariatric surgery: Postoperative nutritional management", section on 'Micronutrient management'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1935.html" rel="external">
          "Hyporesponse to erythropoiesis-stimulating agents (ESAs) in chronic kidney disease", section on 'Our approach to ESA hyporesponsiveness'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H51">
         <span class="h2">
          Efficacy
         </span>
         <span class="headingEndMark">
          —
         </span>
         It has not been established that multivitamin and mineral supplements provide added benefit to a balanced, healthful diet for most individuals [
         <a href="#rid108">
          108
         </a>
         ].
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a 2021 evidence review for the US Preventive Services Task Force (USPSTF) including 84 trials, vitamin and mineral supplementation was associated with little or no benefit in preventing cancer, cardiovascular disease (CVD), or death, with the exception of a small benefit for cancer incidence with multivitamin use [
         <a href="#rid47">
          47
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In a trial conducted among 21,442 older adults in the United States, a daily multivitamin and cocoa extract supplement did not reduce the incidence of invasive cancer compared with placebo (hazard ratio [HR] 0.97, 95% CI 0.86-1.09) [
         <a href="#rid48">
          48
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Consistent with the USPSTF and the US National Institutes of Health (NIH) consensus statement, in otherwise healthy people who have adequate dietary intake and no risk factors for inadequate vitamin status as discussed above, we suggest not taking multivitamin supplementation for primary prevention of chronic diseases because of insufficient evidence of benefit [
         <a href="#rid30">
          30,109
         </a>
         ]. However, many patients wish to take multivitamins based on their own belief systems; we advise that clinicians not struggle against that practice as long as there is no absolute contraindication for an individual patient. Other experts disagree and would recommend more strongly against such supplements [
         <a href="#rid110">
          110
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H52">
         <span class="h2">
          Safety
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the United States, the federal government does not regulate food supplements (vitamins, minerals, and herbs) to assure safety and efficacy [
         <a href="#rid111">
          111
         </a>
         ]. Multivitamins are sold in a variety of combinations and doses, although manufacturers are required to list contents in a standard way, making it easier for consumers to compare brands.
        </p>
        <p>
         Individual vitamin doses in multivitamins are safe for most adults. As examples, the dose of
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         is well below the levels reported to cause an increase in overall mortality, and the dose of
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          beta-carotene
         </a>
         is well below levels associated with lung cancer. The dose of
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          folic acid
         </a>
         is also lower than that found to potentially increase cancer risk.
        </p>
        <p>
         However, there are potential risks of harm with vitamin supplementation. In a 2021 evidence review for the USPSTF including trials of multicomponent multivitamins, although adverse effects were rare, some supplements were associated with higher risk of serious harms (hip fracture [
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         ], hemorrhagic stroke [
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         ], and kidney stones [
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         , calcium]) [
         <a href="#rid47">
          47
         </a>
         ]. Further, some formulations of vitamins sold over the counter may contain several times the RDA of
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         and should be avoided.
        </p>
        <p>
         In addition, some individuals may be harmed by even ordinary doses of
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         . As an example, vitamin A has been shown in observational studies to be a risk factor for osteopenia and fractures in the range ingested by a substantial proportion of the adult population in the United States. People at increased risk of osteopenia, or with relatively high dietary intake of vitamin A, should not take additional supplements containing vitamin A. Additionally, vitamin A is teratogenic at doses as low as 10,000 units daily of supplementation [
         <a href="#rid69">
          69
         </a>
         ]. Although manufacturers have been reducing the amount of vitamin A in multivitamins, supplementation, even at less than 100 percent of the RDA, does not seem prudent in people who are otherwise at increased risk. (See
         <a class="local">
          'Fractures'
         </a>
         above and
         <a class="local">
          'Toxicity at high doses'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H74132982">
         <span class="h1">
          TOXICITY AT HIGH DOSES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Potentially toxic levels of individual vitamins can be achieved easily in people who take very high-potency vitamins, which can be obtained in specialty stores, over the internet, and even in pharmacies. High doses can also be achieved by taking a large number of pills even if the dose per pill is not high. The Institute of Medicine (IOM) and the United States Office of Dietary Supplements has suggested Tolerable Upper Intake Levels (ULs) for specific vitamins, which is the highest daily dose that is unlikely to cause adverse health effects in the general population  (
         <a class="graphic graphic_table graphicRef81151" href="/z/d/graphic/81151.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_table graphicRef69963" href="/z/d/graphic/69963.html" rel="external">
          table 6
         </a>
         ).
        </p>
        <p>
         Water-soluble vitamins (folate,
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         , B vitamins) can generally be tolerated at high doses, with toxicity occurring only at doses thousands of times the Recommended Dietary Allowance (RDA). A possible exception is the risk of kidney stones, which may be increased after doses of vitamin C that are 10 to 25 times the RDA.
        </p>
        <p>
         Fat-soluble vitamins (vitamins A, D, E, K) are generally more toxic than water-soluble vitamins. Vitamin D may cause hypercalcemia at doses as low as 4000 units daily (recommended upper limit) in some people.
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          Vitamin A
         </a>
         in pregnancy is teratogenic at doses as low as several times the RDA (with an apparent threshold at 10,000 units daily of supplemental vitamin A) [
         <a href="#rid69">
          69
         </a>
         ].
         <a class="drug drug_general" data-topicid="9127" href="/z/d/drug information/9127.html" rel="external">
          Beta-carotene
         </a>
         appears to increase the risk of lung cancer in adults who are at high risk because of smoking or asbestos exposure. As discussed above, there are concerns that
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation above 400 units daily may be associated with increased all-cause mortality. (See
         <a class="local">
          'Cancer'
         </a>
         above and
         <a class="local">
          'All-cause mortality'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H54">
         <span class="h1">
          SPECIAL DIETS
         </span>
         <span class="headingEndMark">
          —
         </span>
         People on restricted or special diets may have needs for vitamin supplementation. As an example, adequate
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         levels are strongly affected by dietary intake in addition to absorption. In younger adults, low consumption of animal-source foods is the main cause of low vitamin B12 levels; in older adults, malabsorption of vitamin B12 from foods is the most common cause [
         <a href="#rid112">
          112
         </a>
         ]. The lowest intakes of vitamin B12 are seen in those who eat no animal products, and vitamin B12 intake increases with increasing intake of animal source foods [
         <a href="#rid113">
          113
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/7154.html" rel="external">
          "Treatment of vitamin B12 and folate deficiencies"
         </a>
         .)
        </p>
        <p>
         People who consume a vegan diet (ie, a diet that excludes all animal products, including meat, eggs, milk, and milk products) should take a
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         supplement (at the RDA of 2.4 micrograms daily). They are also at risk for inadequate vitamin D status and should consider a supplement, particularly during winter months [
         <a href="#rid114">
          114
         </a>
         ].
        </p>
        <p>
         Lacto-ovo-vegetarians (ie, those who exclude meat, but consume eggs, milk, and milk products) and lacto-vegetarians (ie, those who exclude meat and eggs, but consume milk and milk products) should also consider supplementation with
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          vitamin B12
         </a>
         .
        </p>
        <p>
         There are many other specialized diets that have not been adequately researched for their nutritional effects. Because most of the vitamins are available in a variety of foods, diets excluding one specific food generally would not be expected to result in deficiency or need for supplementation. By contrast, people who restrict entire categories of foods or consume only a few types of specific foods or groups may be at risk for deficiency of specific vitamins. Reasonable options in such patients are to recommend a daily multivitamin or consider specific testing (eg, 25-hydroxyvitamin D levels) based on the expected nutrient deficiencies in the diet.
        </p>
        <p class="headingAnchor" id="H56">
         <span class="h1">
          RECOMMENDATIONS OF OTHERS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The US Preventive Services Task Force (USPSTF) clinical practice guidelines provide several recommendations for vitamin supplementation in adult populations:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf%2Frecommendation%2Fvitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication&amp;token=SkAWeAWHAE6nzlihCDuZJCQ1izTZ3kj8Qz8f8xvOjOs6YWbGLB0cYLANl6FnuMSR9eLMNX7EpgSgT%2BkryqYBIaNvg%2BLbqyfIG1Io45MkCE4V0ieG6LcT7pJSr1IpoDCqDYS4RdTj%2B2VWkisZvoIO4kU%2BiZnrm4BscrWwP26tLQBywVc27q4hoqhuHGpgjI%2BQ&amp;TOPIC_ID=5368" target="_blank">
          Vitamin, calcium, or combined supplementation for the primary prevention of fractures in community-dwelling adults: Preventive medication
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf%2Frecommendation%2Fvitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication&amp;token=op%2FXyJtJ3INEP7zTGT9%2FzlwBfr5fCirH%2FvxqF1iRS3WgsbR%2FhP%2Bykr47DiMhxIUHLzjPN%2FlBUjBj3bOwNnwn8wTnxqxaEjov1UVQaXK3ahCxr7oGtouiArTYyDSh8jA1B1NACa0T%2BL%2FDWaxqIevCFA%3D%3D&amp;TOPIC_ID=5368" target="_blank">
          Vitamin, mineral, and multivitamin supplementation to prevent cardiovascular disease and cancer: Preventive medication
         </a>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.uspreventiveservicestaskforce.org%2Fuspstf%2Frecommendation%2Ffolic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication&amp;token=HYivevs0S5R6UpKVPCVY6ByyYD%2FuxyJVOYCiFypijhpaaib5u5K5pfJpu7bCLshgLFwS8GIffuOCyjqrWXuc%2Bl0Ur5S5n7TOEQdCS0X9QGr2hFmNdRtJF9hvyQ0xqhishjyJjlydnQxHzNALJQrXbA%3D%3D&amp;TOPIC_ID=5368" target="_blank">
          Folic acid for the prevention of neural tube defects: Preventive medication
         </a>
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1718859072">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/110557.html" rel="external">
          "Society guideline links: Vitamin deficiencies"
         </a>
         and
         <a class="medical medical_society_guidelines" href="/z/d/html/111039.html" rel="external">
          "Society guideline links: Healthy diet in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19037533">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to provide these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/15788.html" rel="external">
          "Patient education: Vitamin D deficiency (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/17169.html" rel="external">
          "Patient education: Vitamin B12 deficiency and folate deficiency (The Basics)"
         </a>
         and
         <a class="medical medical_basics" href="/z/d/html/16895.html" rel="external">
          "Patient education: Vitamin supplements (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topic (see
         <a class="medical medical_patient" href="/z/d/html/2169.html" rel="external">
          "Patient education: Calcium and vitamin D for bone health (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H63268677">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitions of adequate intake
         </strong>
         – There are several ways of defining optimal vitamin intake. Dietary reference intakes (DRIs) represent four concepts: Recommended Dietary Allowance (RDA), Adequate Intake (AI), Estimated Average Requirement (EAR), and Tolerable Upper Intake Level (UL)  (
         <a class="graphic graphic_table graphicRef106207" href="/z/d/graphic/106207.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_table graphicRef51953" href="/z/d/graphic/51953.html" rel="external">
          table 4
         </a>
         and
         <a class="graphic graphic_table graphicRef81151" href="/z/d/graphic/81151.html" rel="external">
          table 5
         </a>
         and
         <a class="graphic graphic_table graphicRef69963" href="/z/d/graphic/69963.html" rel="external">
          table 6
         </a>
         ). We use the RDA, which is the recommended daily intake that is sufficient to meet the dietary requirement of nearly all healthy people. The AI is used when the RDA cannot be determined. (See
         <a class="local">
          'Vitamin deficiency and definitions of adequate intake'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Testing for vitamin deficiencies
         </strong>
         – Although measurement of serum levels of several vitamins is widely available, testing for deficiencies is usually unwarranted. Testing remains appropriate in certain clinical situations where deficiencies are suspected or are part of the clinical evaluation. (See
         <a class="local">
          'Testing'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Role of supplementation of various vitamins in disease prevention
         </strong>
         – There is limited evidence to support vitamin supplementation in the prevention of various conditions.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Folate
         </strong>
         –
         <a class="drug drug_general" data-topicid="8475" href="/z/d/drug information/8475.html" rel="external">
          Folic acid
         </a>
         supplementation during pregnancy can prevent neural tube defects. (See
         <a class="local">
          'Folic acid'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/423.html" rel="external">
          "Preconception and prenatal folic acid supplementation", section on 'Folic acid supplementation for preventing NTDs'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Vitamin D
         </strong>
         – Subclinical vitamin D deficiency may contribute to the development of osteoporosis, falls, and fractures in older adults. Vitamin D supplementation may attenuate bone loss, reduce fracture risk, and reduce falls in deficient persons. (See
         <a class="local">
          'Vitamin D'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/2022.html" rel="external">
          "Vitamin D deficiency in adults: Definition, clinical manifestations, and treatment"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2023.html" rel="external">
          "Calcium and vitamin D supplementation in osteoporosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Antioxidants
         </strong>
         – Although diets high in vegetables and fruits that are rich in antioxidants are associated with a reduced risk of cancer and cardiovascular disease (CVD), there is no evidence to support the use of antioxidant supplements to prevent cancer or atherosclerotic CVD. (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2582.html" rel="external">
          "Overview of vitamin E"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Vitamin A
         </strong>
         <strong>
          and the carotenoids
         </strong>
         – In resource-limited regions,
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          vitamin A
         </a>
         supplementation in children ages 6 to 59 months is advised as it is associated with decreased mortality. (See
         <a class="medical medical_review" href="/z/d/html/2571.html" rel="external">
          "Overview of vitamin A", section on 'Targeted supplementation for disease'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         In some adult populations, supplementation with carotenoids is associated with increased mortality, risk of cancer, risk of osteopenia, and fractures.
         <a class="drug drug_general" data-topicid="10047" href="/z/d/drug information/10047.html" rel="external">
          Vitamin A
         </a>
         in high doses (ie, &gt;10,000 international units) taken during the first trimester of pregnancy has been shown to increase the risk of congenital anomalies. (See
         <a class="local">
          'Vitamin A and the carotenoids'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Vitamin C
         </strong>
         – There is no evidence that
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         supplementation reduces cancer, CVD, or mortality risk. Vitamin C supplementation may also increase the risk for oxalate kidney stones. (See
         <a class="local">
          'Vitamin C'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         <strong>
          Vitamin E
         </strong>
         – Evidence does not support a role for
         <a class="drug drug_general" data-topicid="10049" href="/z/d/drug information/10049.html" rel="external">
          vitamin E
         </a>
         supplementation in the prevention or treatment of cancers, CVD, dementia, or infection. Further, high-dose vitamin E (≥400 units daily) might be associated with increased all-cause mortality. (See
         <a class="local">
          'Vitamin E'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Vitamin B2 (riboflavin)
         </strong>
         – There is no evidence of benefits in supplemental vitamin B2 in healthy people eating a balanced diet. B2 supplementation may have a role in management in adults with episodic migraines. (See
         <a class="local">
          'Vitamin B2 (riboflavin)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Vitamin B6 (
         </strong>
         <a class="drug drug_general" data-topicid="9839" href="/z/d/drug information/9839.html" rel="external">
          pyridoxine
         </a>
         <strong>
          )
         </strong>
         – There is no evidence that vitamin B6 supplementation is associated with a decreased risk of cancer or CVD. (See
         <a class="local">
          'Vitamin B6 (pyridoxine)'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Vitamin B12
         </strong>
         <strong>
          (cobalamin)
         </strong>
         –
         <a class="drug drug_general" data-topicid="9302" href="/z/d/drug information/9302.html" rel="external">
          Vitamin B12
         </a>
         deficiency is associated with neuropsychiatric manifestations and megaloblastic anemia. Vitamin B12 supplementation or testing is reasonable for those at increased risk for poor vitamin B12 intake, those who avoid all meat, fish and poultry, people taking
         <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">
          metformin
         </a>
         , those with alcohol use disorder, and people with little dietary variation or poor-quality diets (such as some older adults and people experiencing poverty)  (
         <a class="graphic graphic_algorithm graphicRef113189" href="/z/d/graphic/113189.html" rel="external">
          algorithm 1
         </a>
         ).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Multivitamins
         </strong>
         – In healthy people with adequate dietary intake, we suggest not taking multivitamin supplementation for the prevention of chronic disease (
         <a class="grade" href="https:///uptodate/show/grade_5" rel="external">
          Grade 2B
         </a>
         ). However, multivitamin supplementation is appropriate to consider for patients at risk for vitamin deficiency, such as those with alcohol use disorder, a poor-quality diet with low fruit and vegetable intake, malabsorption, a vegan diet, prior bariatric surgery, certain errors of metabolism, as well as those receiving hemodialysis or
         <a class="drug drug_general" data-topicid="10307" href="/z/d/drug information/10307.html" rel="external">
          parenteral nutrition
         </a>
         . In addition, we do not struggle to dissuade patients from taking multivitamins if they wish to do so. (See
         <a class="local">
          'Multivitamins'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Concerns over toxicity
         </strong>
         – Potentially toxic levels of individual vitamins can be achieved easily among people who take very high-potency vitamins. Water-soluble vitamins (folate,
         <a class="drug drug_general" data-topicid="9776" href="/z/d/drug information/9776.html" rel="external">
          vitamin C
         </a>
         , B vitamins) are generally tolerated at high doses; fat-soluble vitamins (vitamins A, D, E, K) are generally more toxic than water-soluble vitamins. (See
         <a class="local">
          'Toxicity at high doses'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1152956">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Robert H Fletcher, MD, MSc, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Heaney RP. Vitamin D--baseline status and effective dose. N Engl J Med 2012; 367:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris MC, Tangney CC. A potential design flaw of randomized trials of vitamin supplements. JAMA 2011; 305:1348.
          </a>
         </li>
         <li class="breakAll">
          Centers for Disease Control and Prevention. Guidance for evaluating the nutritional status and growth in refugee children during the domestic medical screening examination. Available at: https://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/nutrition-growth.html (Accessed on April 05, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martin CA, Gowda U, Renzaho AM. The prevalence of vitamin D deficiency among dark-skinned populations according to their stage of migration and region of birth: A meta-analysis. Nutrition 2016; 32:21.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oakley GP Jr. Eat right and take a multivitamin. N Engl J Med 1998; 338:1060.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Smith AD, Kim YI, Refsum H. Is folic acid good for everyone? Am J Clin Nutr 2008; 87:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Botto LD, Olney RS, Erickson JD. Vitamin supplements and the risk for congenital anomalies other than neural tube defects. Am J Med Genet C Semin Med Genet 2004; 125C:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Czeizel AE, Medveczky E. Periconceptional multivitamin supplementation and multimalformed offspring. Obstet Gynecol 2003; 102:1255.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goh YI, Bollano E, Einarson TR, Koren G. Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis. J Obstet Gynaecol Can 2006; 28:680.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Botto LD, Mulinare J, Erickson JD. Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps. Am J Med Genet A 2003; 121A:95.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Berry RJ, Li Z, Erickson JD, et al. Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention. N Engl J Med 1999; 341:1485.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study. Ann Intern Med 1998; 129:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giovannucci E, Rimm EB, Ascherio A, et al. Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 1995; 87:265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lewis SJ, Harbord RM, Harris R, Smith GD. Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk. J Natl Cancer Inst 2006; 98:1607.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Larsson SC, Giovannucci E, Wolk A. Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 2007; 99:64.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cole BF, Baron JA, Sandler RS, et al. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA 2007; 297:2351.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Logan RF, Grainge MJ, Shepherd VC, et al. Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology 2008; 134:29.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ebbing M, Bønaa KH, Nygård O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA 2009; 302:2119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang SM, Cook NR, Albert CM, et al. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. JAMA 2008; 300:2012.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vollset SE, Clarke R, Lewington S, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals. Lancet 2013; 381:1029.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang SS, Rosenson RS. Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease. Cardiovasc Drugs Ther 2018; 32:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sawaengsri H, Bergethon PR, Qiu WQ, et al. Transcobalamin 776C→G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake. Am J Clin Nutr 2016; 104:1665.
          </a>
         </li>
         <li class="breakAll">
          Dietary Reference Intakes for Calcium and Vitamin D, Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium. (Ed), National Academies Press (US), Washington (DC) 2011.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marriott BM. Vitamin D supplementation: a word of caution. Ann Intern Med 1997; 127:231.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, et al. Effect of Vitamin D on falls: a meta-analysis. JAMA 2004; 291:1999.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jackson C, Gaugris S, Sen SS, Hosking D. The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis. QJM 2007; 100:185.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339:b3692.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillespie LD, Robertson MC, Gillespie WJ, et al. Interventions for preventing falls in older people living in the community. Cochrane Database Syst Rev 2009; :CD007146.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cameron ID, Murray GR, Gillespie LD, et al. Interventions for preventing falls in older people in nursing care facilities and hospitals. Cochrane Database Syst Rev 2010; :CD005465.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           US Preventive Services Task Force, Mangione CM, Barry MJ, et al. Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement. JAMA 2022; 327:2326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meyer HE, Holvik K, Lips P. Should vitamin D supplements be recommended to prevent chronic diseases? BMJ 2015; 350:h321.
          </a>
         </li>
         <li class="breakAll">
          Vitamin D. COVID-19 Treatment guidelines. National Institutes of Health. Available at: https://www.covid19treatmentguidelines.nih.gov/therapies/supplements/vitamin-d/ (Accessed on September 21, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Diaz MN, Frei B, Vita JA, Keaney JF Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997; 337:408.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Savenkova ML, Mueller DM, Heinecke JW. Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein. J Biol Chem 1994; 269:20394.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsimikas S, Brilakis ES, Miller ER, et al. Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease. N Engl J Med 2005; 353:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Forman HJ, Davies KJ, Ursini F. How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo. Free Radic Biol Med 2014; 66:24.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jha P, Flather M, Lonn E, et al. The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123:860.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stanner SA, Hughes J, Kelly CN, Buttriss J. A review of the epidemiological evidence for the 'antioxidant hypothesis'. Public Health Nutr 2004; 7:407.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabung FK, Smith-Warner SA, Chavarro JE, et al. Development and Validation of an Empirical Dietary Inflammatory Index. J Nutr 2016; 146:1560.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tabung FK, Smith-Warner SA, Chavarro JE, et al. An Empirical Dietary Inflammatory Pattern Score Enhances Prediction of Circulating Inflammatory Biomarkers in Adults. J Nutr 2017; 147:1567.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Li J, Lee DH, Hu J, et al. Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the U.S. J Am Coll Cardiol 2020; 76:2181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bjelakovic G, Nikolova D, Simonetti RG, Gluud C. Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis. Lancet 2004; 364:1219.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Al-Khudairy L, Flowers N, Wheelhouse R, et al. Vitamin C supplementation for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev 2017; 3:CD011114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jenkins DJA, Spence JD, Giovannucci EL, et al. Supplemental Vitamins and Minerals for CVD Prevention and Treatment. J Am Coll Cardiol 2018; 71:2570.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev 2012; :CD007176.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Connor EA, Evans CV, Ivlev I, et al. Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA 2022; 327:2334.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sesso HD, Rist PM, Aragaki AK, et al. Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial. Am J Clin Nutr 2022; 115:1501.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. Vitamin A supplementation in infants and children 6-59 months of age. 2011. Available at: https://apps.who.int/iris/bitstream/handle/10665/44664/9789241501767_eng.pdf (Accessed on April 05, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Imdad A, Mayo-Wilson E, Haykal MR, et al. Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age. Cochrane Database Syst Rev 2022; 3:CD008524.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330:1029.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Omenn GS, Goodman GE, Thornquist MD, et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334:1150.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Virtamo J, Pietinen P, Huttunen JK, et al. Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up. JAMA 2003; 290:476.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hennekens CH, Buring JE, Manson JE, et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334:1145.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee IM, Cook NR, Manson JE, et al. Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study. J Natl Cancer Inst 1999; 91:2102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst 2009; 101:14.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kushi LH, Fee RM, Sellers TA, et al. Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study. Am J Epidemiol 1996; 144:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hunter DJ, Manson JE, Colditz GA, et al. A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer. N Engl J Med 1993; 329:234.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zhang S, Hunter DJ, Forman MR, et al. Dietary carotenoids and vitamins A, C, and E and risk of breast cancer. J Natl Cancer Inst 1999; 91:547.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tamimi RM, Hankinson SE, Campos H, et al. Plasma carotenoids, retinol, and tocopherols and risk of breast cancer. Am J Epidemiol 2005; 161:153.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Greenberg ER, Baron JA, Tosteson TD, et al. A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med 1994; 331:141.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Heinonen OP, Albanes D, Virtamo J, et al. Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. J Natl Cancer Inst 1998; 90:440.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vivekananthan DP, Penn MS, Sapp SK, et al. Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials. Lancet 2003; 361:2017.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fawzi WW, Chalmers TC, Herrera MG, Mosteller F. Vitamin A supplementation and child mortality. A meta-analysis. JAMA 1993; 269:898.
          </a>
         </li>
         <li class="breakAll">
          World Health Organization. Guideline: Vitamin A supplementation in infants and children 6–59 months of age. 2011. Available at: https://apps.who.int/iris/bitstream/handle/10665/44664/9789241501767_eng.pdf (Accessed on March 18, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Melhus H, Michaëlsson K, Kindmark A, et al. Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture. Ann Intern Med 1998; 129:770.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Feskanich D, Singh V, Willett WC, Colditz GA. Vitamin A intake and hip fractures among postmenopausal women. JAMA 2002; 287:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Michaëlsson K, Lithell H, Vessby B, Melhus H. Serum retinol levels and the risk of fracture. N Engl J Med 2003; 348:287.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rothman KJ, Moore LL, Singer MR, et al. Teratogenicity of high vitamin A intake. N Engl J Med 1995; 333:1369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Coulter ID, Hardy ML, Morton SC, et al. Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer. J Gen Intern Med 2006; 21:735.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA 2009; 301:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang L, Sesso HD, Glynn RJ, et al. Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial. Am J Clin Nutr 2014; 100:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hemilä H, Chalker E. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev 2013; :CD000980.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans JR, Lawrenson JG. Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration. Cochrane Database Syst Rev 2017; 7:CD000253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller ER 3rd, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med 2005; 142:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chan JM, Stampfer MJ, Ma J, et al. Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States. Cancer Epidemiol Biomarkers Prev 1999; 8:893.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kirsh VA, Hayes RB, Mayne ST, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst 2006; 98:245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Woodson K, Tangrea JA, Barrett MJ, et al. Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers. J Natl Cancer Inst 1999; 91:1738.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA 2005; 294:56.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA 2005; 293:1338.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301:39.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Virtamo J, Taylor PR, Kontto J, et al. Effects of α-tocopherol and β-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study. Int J Cancer 2014; 135:178.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Klein EA, Thompson IM Jr, Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011; 306:1549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schürks M, Glynn RJ, Rist PM, et al. Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials. BMJ 2010; 341:c5702.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Masaki KH, Losonczy KG, Izmirlian G, et al. Association of vitamin E and C supplement use with cognitive function and dementia in elderly men. Neurology 2000; 54:1265.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Engelhart MJ, Geerlings MI, Ruitenberg A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287:3223.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Morris MC, Evans DA, Bienias JL, et al. Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study. JAMA 2002; 287:3230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yaffe K, Clemons TE, McBee WL, et al. Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial. Neurology 2004; 63:1705.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kang JH, Cook N, Manson J, et al. A randomized trial of vitamin E supplementation and cognitive function in women. Arch Intern Med 2006; 166:2462.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meydani SN, Meydani M, Blumberg JB, et al. Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial. JAMA 1997; 277:1380.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Serafini M. Dietary vitamin E and T cell-mediated function in the elderly: effectiveness and mechanism of action. Int J Dev Neurosci 2000; 18:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Girodon F, Galan P, Monget AL, et al. Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network. Arch Intern Med 1999; 159:748.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meydani SN, Leka LS, Fine BC, et al. Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial. JAMA 2004; 292:828.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Graat JM, Schouten EG, Kok FJ. Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial. JAMA 2002; 288:715.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Glynn RJ, Ridker PM, Goldhaber SZ, et al. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study. Circulation 2007; 116:1497.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Christen WG, Glynn RJ, Chew EY, Buring JE. Vitamin E and age-related macular degeneration in a randomized trial of women. Ophthalmology 2010; 117:1163.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Omenn GS, Beresford SA, Motulsky AG. Preventing coronary heart disease: B vitamins and homocysteine. Circulation 1998; 97:421.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bazzano LA, Reynolds K, Holder KN, He J. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA 2006; 296:2720.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wang X, Qin X, Demirtas H, et al. Efficacy of folic acid supplementation in stroke prevention: a meta-analysis. Lancet 2007; 369:1876.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Martí-Carvajal AJ, Solà I, Lathyris D, Salanti G. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev 2009; :CD006612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Miller ER 3rd, Juraschek S, Pastor-Barriuso R, et al. Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels. Am J Cardiol 2010; 106:517.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lee M, Hong KS, Chang SC, Saver JL. Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis. Stroke 2010; 41:1205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mocellin S, Briarava M, Pilati P. Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis. J Natl Cancer Inst 2017; 109:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dary O. Establishing safe and potentially efficacious fortification contents for folic acid and vitamin B12. Food Nutr Bull 2008; 29:S214.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Malouf R, Grimley Evans J. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Cochrane Database Syst Rev 2008; :CD004514.
          </a>
         </li>
         <li class="breakAll">
          Dietary Guidelines for Americans. Building a healthy eating routine as you get older. US Department of Health and Human Services. Available at: https://www.dietaryguidelines.gov/sites/default/files/2021-12/DGA_OlderAdults_FactSheet-508c.pdf (Accessed on May 21, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sobczyńska-Malefora A, Smith AD. Vitamin B-12. Adv Nutr 2022; 13:2061.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Huang HY, Caballero B, Chang S, et al. The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference. Ann Intern Med 2006; 145:372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention. NIH Consens State Sci Statements 2006; 23:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Guallar E, Stranges S, Mulrow C, et al. Enough is enough: Stop wasting money on vitamin and mineral supplements. Ann Intern Med 2013; 159:850.
          </a>
         </li>
         <li class="breakAll">
          US Food and Drug Administration. Dietary supplements proposed and final rules. January 2022. Available at: https://www.fda.gov/food/dietary-supplements-guidance-documents-regulatory-information/dietary-supplements-proposed-and-final-rules (Accessed on March 24, 2022).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Allen LH. How common is vitamin B-12 deficiency? Am J Clin Nutr 2009; 89:693S.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Davey GK, Spencer EA, Appleby PN, et al. EPIC-Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK. Public Health Nutr 2003; 6:259.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Outila TA, Kärkkäinen MU, Seppänen RH, Lamberg-Allardt CJ. Dietary intake of vitamin D in premenopausal, healthy vegans was insufficient to maintain concentrations of serum 25-hydroxyvitamin D and intact parathyroid hormone within normal ranges during the winter in Finland. J Am Diet Assoc 2000; 100:434.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5368 Version 76.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22762324" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Vitamin D--baseline status and effective dose.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21467288" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : A potential design flaw of randomized trials of vitamin supplements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21467288" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : A potential design flaw of randomized trials of vitamin supplements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26643747" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : The prevalence of vitamin D deficiency among dark-skinned populations according to their stage of migration and region of birth: A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9535672" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Eat right and take a multivitamin.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18326588" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Is folic acid good for everyone?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14755429" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Vitamin supplements and the risk for congenital anomalies other than neural tube defects.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14662212" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Periconceptional multivitamin supplementation and multimalformed offspring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17022907" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Prenatal multivitamin supplementation and rates of congenital anomalies: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12910485" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Do multivitamin or folic acid supplements reduce the risk for congenital heart defects? Evidence and gaps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10559448" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Prevention of neural-tube defects with folic acid in China. China-U.S. Collaborative Project for Neural Tube Defect Prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9758570" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Multivitamin use, folate, and colon cancer in women in the Nurses' Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7707417" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Alcohol, low-methionine--low-folate diets, and risk of colon cancer in men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17105984" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Meta-analyses of observational and genetic association studies of folate intakes or levels and breast cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17202114" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Folate and risk of breast cancer: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17551129" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Folic acid for the prevention of colorectal adenomas: a randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18022173" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Aspirin and folic acid for the prevention of recurrent colorectal adenomas.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19920236" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Cancer incidence and mortality after treatment with folic acid and vitamin B12.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18984888" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23352552" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29679304" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Analytic Approaches for the Treatment of Hyperhomocysteinemia and Its Impact on Vascular Disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27733392" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Transcobalamin 776C→G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27733392" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Transcobalamin 776C→G polymorphism is associated with peripheral neuropathy in elderly individuals with high folate intake.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9245230" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Vitamin D supplementation: a word of caution.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15113819" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effect of Vitamin D on falls: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17308327" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19797342" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19370674" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Interventions for preventing falls in older people living in the community.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20091578" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Interventions for preventing falls in older people in nursing care facilities and hospitals.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35727271" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: US Preventive Services Task Force Recommendation Statement.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25633148" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Should vitamin D supplements be recommended to prevent chronic diseases?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25633148" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Should vitamin D supplements be recommended to prevent chronic diseases?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9241131" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Antioxidants and atherosclerotic heart disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2648148" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8051134" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Tyrosyl radical generated by myeloperoxidase is a physiological catalyst for the initiation of lipid peroxidation in low density lipoprotein.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16000355" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Oxidized phospholipids, Lp(a) lipoprotein, and coronary artery disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23747930" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : How do nutritional antioxidants really work: nucleophilic tone and para-hormesis versus free radical scavenging in vivo.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7486470" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : The antioxidant vitamins and cardiovascular disease. A critical review of epidemiologic and clinical trial data.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15153272" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : A review of the epidemiological evidence for the 'antioxidant hypothesis'.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27358416" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Development and Validation of an Empirical Dietary Inflammatory Index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28659407" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : An Empirical Dietary Inflammatory Pattern Score Enhances Prediction of Circulating Inflammatory Biomarkers in Adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33153576" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Dietary Inflammatory Potential and Risk of Cardiovascular Disease Among Men and Women in the U.S.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15464182" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Antioxidant supplements for prevention of gastrointestinal cancers: a systematic review and meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28301692" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Vitamin C supplementation for the primary prevention of cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29852980" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Supplemental Vitamins and Minerals for CVD Prevention and Treatment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22419320" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35727272" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Vitamin and Mineral Supplements for the Primary Prevention of Cardiovascular Disease and Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35294969" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35294969" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Multivitamins in the prevention of cancer and cardiovascular disease: the COcoa Supplement and Multivitamin Outcomes Study (COSMOS) randomized clinical trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35294044" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8127329" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8602180" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12876090" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Incidence of cancer and mortality following alpha-tocopherol and beta-carotene supplementation: a postintervention follow-up.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8602179" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10601381" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Beta-carotene supplementation and incidence of cancer and cardiovascular disease: the Women's Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19116389" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8678048" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Intake of vitamins A, C, and E and postmenopausal breast cancer. The Iowa Women's Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8292129" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : A prospective study of the intake of vitamins C, E, and A and the risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10088626" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Dietary carotenoids and vitamins A, C, and E and risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15632265" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Plasma carotenoids, retinol, and tocopherols and risk of breast cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8008027" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9521168" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12814711" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8426449" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Vitamin A supplementation and child mortality. A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8426449" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Vitamin A supplementation and child mortality. A meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9841582" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Excessive dietary intake of vitamin A is associated with reduced bone mineral density and increased risk for hip fracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11754708" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Vitamin A intake and hip fractures among postmenopausal women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12540641" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Serum retinol levels and the risk of fracture.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7477116" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Teratogenicity of high vitamin A intake.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16808775" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Antioxidants vitamin C and vitamin e for the prevention and treatment of cancer.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19066368" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25008853" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Vitamin E and C supplementation and risk of cancer in men: posttrial follow-up in the Physicians' Health Study II randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23440782" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Vitamin C for preventing and treating the common cold.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28756617" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Antioxidant vitamin and mineral supplements for preventing age-related macular degeneration.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15537682" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10548318" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Supplemental vitamin E intake and prostate cancer risk in a large cohort of men in the United States.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16478743" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10528024" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Serum alpha-tocopherol and subsequent risk of lung cancer among male smokers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15998891" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15769967" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19066370" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24338499" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Effects ofα-tocopherol andβ-carotene supplementation on cancer incidence and mortality: 18-year postintervention follow-up of the Alpha-tocopherol, Beta-carotene Cancer Prevention Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21990298" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21051774" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Effects of vitamin E on stroke subtypes: meta-analysis of randomised controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10746596" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Association of vitamin E and C supplement use with cognitive function and dementia in elderly men.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12076218" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Dietary intake of antioxidants and risk of Alzheimer disease.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12076219" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Dietary intake of antioxidant nutrients and the risk of incident Alzheimer disease in a biracial community study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15534261" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Impact of antioxidants, zinc, and copper on cognition in the elderly: a randomized, controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17159011" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : A randomized trial of vitamin E supplementation and cognitive function in women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9134944" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Vitamin E supplementation and in vivo immune response in healthy elderly subjects. A randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10817923" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Dietary vitamin E and T cell-mediated function in the elderly: effectiveness and mechanism of action.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10218756" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Impact of trace elements and vitamin supplementation on immunity and infections in institutionalized elderly patients: a randomized controlled trial. MIN. VIT. AOX. geriatric network.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15315997" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : Vitamin E and respiratory tract infections in elderly nursing home residents: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12169075" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Effect of daily vitamin E and multivitamin-mineral supplementation on acute respiratory tract infections in elderly persons: a randomized controlled trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17846285" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20153900" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Vitamin E and age-related macular degeneration in a randomized trial of women.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9490234" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Preventing coronary heart disease: B vitamins and homocysteine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17164458" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17544768" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Efficacy of folic acid supplementation in stroke prevention: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19821378" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Homocysteine lowering interventions for preventing cardiovascular events.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20691310" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Meta-analysis of folic acid supplementation trials on risk of cardiovascular disease and risk interaction with baseline homocysteine levels.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20413740" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Efficacy of homocysteine-lowering therapy with folic Acid in stroke prevention: a meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28376200" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Vitamin B6 and Cancer Risk: A Field Synopsis and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18709896" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : Establishing safe and potentially efficacious fortification contents for folic acid and vitamin B12.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18843658" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18843658" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35348594" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Vitamin B-12.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16880453" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : The efficacy and safety of multivitamin and mineral supplement use to prevent cancer and chronic disease in adults: a systematic review for a National Institutes of Health state-of-the-science conference.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17332802" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : NIH State-of-the-Science Conference Statement on Multivitamin/Mineral Supplements and Chronic Disease Prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24490268" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Enough is enough: Stop wasting money on vitamin and mineral supplements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24490268" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Enough is enough: Stop wasting money on vitamin and mineral supplements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19116323" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : How common is vitamin B-12 deficiency?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12740075" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : EPIC-Oxford: lifestyle characteristics and nutrient intakes in a cohort of 33 883 meat-eaters and 31 546 non meat-eaters in the UK.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10767899" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Dietary intake of vitamin D in premenopausal, healthy vegans was insufficient to maintain concentrations of serum 25-hydroxyvitamin D and intact parathyroid hormone within normal ranges during the winter in Finland.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
